BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
  • Homepage
  • Online Submission
Number of total visits
30595753
Number of visits today
3544
Number of downloads
12993429
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Wang K, Michelakos T, Wang B, Shang Z, DeLeo AB, Duan Z, Hornicek FJ, Schwab JH, Wang X. Targeting cancer stem cells by disulfiram and copper sensitizes radioresistant chondrosarcoma to radiation. Cancer Lett 2021;505:37-48. [PMID: 33582212 DOI: 10.1016/j.canlet.2021.02.002] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Liu CC, Wu CL, Lin MX, Sze CI, Gean PW. Disulfiram Sensitizes a Therapeutic-Resistant Glioblastoma to the TGF-β Receptor Inhibitor. Int J Mol Sci 2021;22:10496. [PMID: 34638842 DOI: 10.3390/ijms221910496] [Reference Citation Analysis]
2 Xu Y, Lu L, Luo J, Wang L, Zhang Q, Cao J, Jiao Y. Disulfiram Alone Functions as a Radiosensitizer for Pancreatic Cancer Both In Vitro and In Vivo. Front Oncol 2021;11:683695. [PMID: 34631519 DOI: 10.3389/fonc.2021.683695] [Reference Citation Analysis]
3 Lu Y, Pan Q, Gao W, Pu Y, Luo K, He B, Gu Z. Leveraging disulfiram to treat cancer: Mechanisms of action, delivery strategies, and treatment regimens. Biomaterials 2021;281:121335. [PMID: 34979419 DOI: 10.1016/j.biomaterials.2021.121335] [Reference Citation Analysis]
4 Zhao L, Wang X, Jiang M, Wu X, Zhang M, Guan X, Ma J, Zhang W. A nanosystem of copper(II)-disulfiram for cancer treatment with high efficacy and few side effects. Front Mater Sci 2021;15:553-66. [DOI: 10.1007/s11706-021-0576-2] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2022 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345